Retroprosthetic membranes in AlphaCor patients: risk factors and prevention

Celia R Hicks1, Stephen Hamilton

  • 1Biomaterials Research Centre, Lions Eye Institute, University of Western Australia, Perth, Australia. crhicks@cyllene.uwa.edu.au

Cornea
|July 15, 2005
PubMed
Abstract

Insights

Retroprosthetic membrane (RPM) formation after AlphaCor implantation is linked to systemic factors like diabetes and hypertension, not just eye history. Early intervention and preventive measures are key to minimizing this complication.

Area of Science:

  • Ophthalmology
  • Biomaterials Science
  • Corneal Surgery

Background:

  • Retroprosthetic membranes (RPMs) are a known complication of keratoprostheses.
  • Previous studies have reported RPMs with various devices without clear causative factors.

Purpose of the Study:

  • To investigate the incidence of RPM formation with the AlphaCor keratoprosthesis.
  • To identify systemic and perioperative risk factors associated with RPM development.
  • To explore strategies for RPM prevention and management.

Main Methods:

  • Retrospective review of AlphaCor implantation cases.
  • Analysis of patient data, case histories, and relevant medical literature.

Main Results:

  • RPMs were observed in 9.3% of AlphaCor cases (14 out of 150).
  • Significant associations found with systemic risk factors including race, hypertension, and diabetes mellitus.
  • Histological analysis revealed fibrovascular tissue similar to scarred corneal tissue.

Conclusions:

  • Systemic factors, particularly diabetes, play a significant role in RPM formation with AlphaCor.
  • Perioperative management and preventive strategies are crucial for mitigating RPM risk.
  • Consideration of therapies like steroids, NSAIDs, heparin, or tPA in high-risk patients may reduce incidence.